abstract |
New substituted benzazole compounds of formula (I) and methods for inhibiting Raf kinase activity in a human or animal subject are described. Compositions of the new compounds can be used either alone or in combination with at least one additional agent for the treatment of a disorder mediated by Raf kinase, such as cancer. |